{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:07:57Z","timestamp":1761311277048},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The authors acknowledge Shiraz University of Medical Sciences."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11011-017-0096-z","type":"journal-article","created":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T14:44:30Z","timestamp":1503326670000},"page":"2139-2142","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Concurrent assessment of calpain and caspase3 activities in brains of mice with acetaminophen-induced acute hepatic encephalopathy"],"prefix":"10.1007","volume":"32","author":[{"given":"Bahareh","family":"Shabrang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akram","family":"Jamshidzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Farjam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azin","family":"Ebrahimpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Koohi-Hosseinabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"key":"96_CR1","doi-asserted-by":"publisher","first-page":"e13685","DOI":"10.5812\/hepatmon.13685","volume":"13","author":"S Ashkani Esfahani","year":"2013","unstructured":"Ashkani Esfahani S, Esmaeilzadeh E, Bagheri F, Emami Y, Farjam M (2013) The effect of co-enzyme q10 on acute liver damage in rats, a biochemical and pathological study. Hepat Mon 13:e13685. \nhttps:\/\/doi.org\/10.5812\/hepatmon.13685","journal-title":"Hepat Mon"},{"key":"96_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11011-007-9072-3","volume":"22","author":"R Butterworth","year":"2007","unstructured":"Butterworth R (2007) Neuronal cell death in hepatic encephalopathy. Metab Brain Dis 22:309\u2013320. \nhttps:\/\/doi.org\/10.1007\/s11011-007-9072-3","journal-title":"Metab Brain Dis"},{"key":"96_CR3","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1478-3231.2009.02034.x","volume":"29","author":"RF Butterworth","year":"2009","unstructured":"Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht J, Blei AT, Members of the ICoEMoHE (2009) Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int: Off J Int Assoc Study Liver 29:783\u2013788. \nhttps:\/\/doi.org\/10.1111\/j.1478-3231.2009.02034.x","journal-title":"Liver Int: Off J Int Assoc Study Liver"},{"key":"96_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s12017-013-8283-5","volume":"16","author":"O Cauli","year":"2014","unstructured":"Cauli O et al (2014) Blocking NMDA receptors delays death in rats with acute liver failure by dual protective mechanisms in kidney and brain. NeuroMolecular Med 16:360\u2013375. \nhttps:\/\/doi.org\/10.1007\/s12017-013-8283-5","journal-title":"NeuroMolecular Med"},{"key":"96_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0168-8278(05)80462-3","volume":"20","author":"RJ Knegt de","year":"1994","unstructured":"de Knegt RJ, Schalm SW, van der Rijt CC, Fekkes D, Dalm E, Hekking-Weyma I (1994) Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis. J Hepatology 20:19\u201326","journal-title":"J Hepatology"},{"key":"96_CR6","first-page":"164","volume":"14","author":"M Farjam","year":"2012","unstructured":"Farjam M, Dehdab P, Abbassnia F, Mehrabani D, Tanideh N, Pakbaz S, Imanieh MH (2012) Thioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes. Iran Red Crescent Med J 14:164\u2013170","journal-title":"Iran Red Crescent Med J"},{"key":"96_CR7","first-page":"695","volume":"13","author":"M Farjam","year":"2014","unstructured":"Farjam M, Beigi Zarandi FB, Farjadian S, Geramizadeh B, Nikseresht AR, Panjehshahin MR (2014a) Inhibition of NR2B-containing N-methyl-D-aspartate receptors (NMDARs) in experimental autoimmune encephalomyelitis, a model of multiple sclerosis. Iran J Pharm Res: IJPR 13:695\u2013705","journal-title":"Iran J Pharm Res: IJPR"},{"key":"96_CR8","doi-asserted-by":"publisher","unstructured":"Farjam M, Fakhraei B, Hosseinabadi OK (2014b) Calpain in acute hepatic encephalopathy: a player in pathophysiology and a possible target for pharmacological intervention. Prensa Med Argent 100:2. \nhttps:\/\/doi.org\/10.4172\/lpma.1000122","DOI":"10.4172\/lpma.1000122"},{"key":"96_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00580-014-1883-0","volume":"23","author":"M Farjam","year":"2014","unstructured":"Farjam M, Mehrabani D, Abbassnia F (2014c) The healing effect of Curcuma longa on liver in experimental acute hepatic encephalopathy of rat. Comp Clin Pathol 23:4","journal-title":"Comp Clin Pathol"},{"key":"96_CR10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0016-5085(99)70241-6","volume":"116","author":"V Kohli","year":"1999","unstructured":"Kohli V, Madden JF, Bentley RC, Clavien PA (1999) Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. Gastroenterology 116:168\u2013178","journal-title":"Gastroenterology"},{"key":"96_CR11","doi-asserted-by":"publisher","unstructured":"Kristiansen RG, Rose CF, Ytrebo LM (2016) Glycine and hyperammonemia: potential target for the treatment of hepatic encephalopathy. Metab Brain Dis. \nhttps:\/\/doi.org\/10.1007\/s11011-016-9858-2","DOI":"10.1007\/s11011-016-9858-2"},{"key":"96_CR12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0041-008X(03)00250-3","volume":"191","author":"PB Limaye","year":"2003","unstructured":"Limaye PB, Apte UM, Shankar K, Bucci TJ, Warbritton A, Mehendale HM (2003) Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants. Toxicol Appl Pharmacol 191:211\u2013226","journal-title":"Toxicol Appl Pharmacol"},{"key":"96_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1385\/1-59259-050-0:219","volume":"144","author":"JK Newcomb","year":"2000","unstructured":"Newcomb JK, Pike BR, Zhao X, Hayes RL (2000) Concurrent assessment of calpain and caspase-3 activity by means of western blots of protease-specific spectrin breakdown products. Methods Mol Biol 144:219\u2013223. \nhttps:\/\/doi.org\/10.1385\/1-59259-050-0:219","journal-title":"Methods Mol Biol"},{"key":"96_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/MEG.0000000000000529","volume":"28","author":"DL Shawcross","year":"2016","unstructured":"Shawcross DL et al (2016) How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist. Eur J Gastroenterol Hepatol 28:146\u2013152. \nhttps:\/\/doi.org\/10.1097\/MEG.0000000000000529","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"96_CR15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/hep.510250406","volume":"25","author":"BA Vogels","year":"1997","unstructured":"Vogels BA, Maas MA, Daalhuisen J, Quack G, Chamuleau RA (1997) Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 25:820\u2013827. \nhttps:\/\/doi.org\/10.1002\/hep.510250406","journal-title":"Hepatology"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-017-0096-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-017-0096-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-017-0096-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T03:20:46Z","timestamp":1510370446000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-017-0096-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,21]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1007\/s11011-017-0096-z","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,21]]}}}